Clinical Trials · NCT04704713
Afamelanotide in Patients Suffering From Polymorphic Light Eruption (PLE)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Clinuvel Pharmaceuticals Limited
- Enrollment
- 31
- Start date
- May 2010
- Locations
- See registry
- Primary endpoint
- Severity of PLE Related Pruritus Recorded Using an 11-point Likert Scale